Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-07-002071
Filing Date
2007-02-14
Accepted
2007-02-14 16:40:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOC ONE filing.txt SC 13G 6080
  Complete submission text file 0000315066-07-002071.txt   7999
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR CORP (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 161144965 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Business Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111 (212) 887-6500
Omrix Biopharmaceuticals, Inc. (Subject) CIK: 0001349426 (see all company filings)

EIN.: 522147005 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82558 | Film No.: 07621526
SIC: 2836 Biological Products, (No Diagnostic Substances)